SK150797A3 - Antifungal composition - Google Patents

Antifungal composition Download PDF

Info

Publication number
SK150797A3
SK150797A3 SK1507-97A SK150797A SK150797A3 SK 150797 A3 SK150797 A3 SK 150797A3 SK 150797 A SK150797 A SK 150797A SK 150797 A3 SK150797 A3 SK 150797A3
Authority
SK
Slovakia
Prior art keywords
azole
composition
preparation
terbinafine
fungicidal
Prior art date
Application number
SK1507-97A
Other languages
English (en)
Slovak (sk)
Inventor
Josef G Meingassner
Neil S Ryder
Original Assignee
Ciba Geigy Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Ciba Geigy Ag filed Critical Ciba Geigy Ag
Publication of SK150797A3 publication Critical patent/SK150797A3/sk

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/13Amines
    • A61K31/135Amines having aromatic rings, e.g. ketamine, nortriptyline
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04Antibacterial agents
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/10Antimycotics
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Epidemiology (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Communicable Diseases (AREA)
  • Oncology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Agricultural Chemicals And Associated Chemicals (AREA)
  • Materials For Medical Uses (AREA)
SK1507-97A 1995-05-12 1996-05-10 Antifungal composition SK150797A3 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
GBGB9509631.9A GB9509631D0 (en) 1995-05-12 1995-05-12 Antifungal combination
PCT/EP1996/002022 WO1996035423A1 (en) 1995-05-12 1996-05-10 Antifungal composition

Publications (1)

Publication Number Publication Date
SK150797A3 true SK150797A3 (en) 1998-05-06

Family

ID=10774361

Family Applications (1)

Application Number Title Priority Date Filing Date
SK1507-97A SK150797A3 (en) 1995-05-12 1996-05-10 Antifungal composition

Country Status (26)

Country Link
US (1) US5985906A (ko)
EP (1) EP0824350B1 (ko)
JP (1) JPH11504931A (ko)
KR (1) KR100443535B1 (ko)
CN (1) CN1100539C (ko)
AT (1) ATE246504T1 (ko)
AU (1) AU712914B2 (ko)
CA (1) CA2219651C (ko)
CY (1) CY2496B1 (ko)
CZ (1) CZ291144B6 (ko)
DE (1) DE69629367T2 (ko)
DK (1) DK0824350T3 (ko)
ES (1) ES2205042T3 (ko)
FI (1) FI120079B (ko)
GB (1) GB9509631D0 (ko)
HK (1) HK1016064A1 (ko)
HU (1) HU224920B1 (ko)
IL (2) IL118219A0 (ko)
MX (1) MX9708699A (ko)
NO (1) NO317030B1 (ko)
PL (1) PL322749A1 (ko)
PT (1) PT824350E (ko)
SK (1) SK150797A3 (ko)
TW (1) TW464492B (ko)
WO (1) WO1996035423A1 (ko)
ZA (1) ZA963754B (ko)

Families Citing this family (16)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6187757B1 (en) 1995-06-07 2001-02-13 Ariad Pharmaceuticals, Inc. Regulation of biological events using novel compounds
US7067526B1 (en) 1999-08-24 2006-06-27 Ariad Gene Therapeutics, Inc. 28-epirapalogs
AU783158B2 (en) * 1999-08-24 2005-09-29 Ariad Pharmaceuticals, Inc. 28-epirapalogs
GB0001315D0 (en) * 2000-01-20 2000-03-08 Novartis Ag Organic compounds
GB0003932D0 (en) * 2000-02-18 2000-04-12 Novartis Ag Pharmaceutical compositions
US6673373B2 (en) 2001-02-01 2004-01-06 Carlsbad Technology Inc. Antifungal formulation and the methods for manufacturing and using the same
US7244703B2 (en) 2001-06-22 2007-07-17 Bentley Pharmaceuticals, Inc. Pharmaceutical compositions and methods for peptide treatment
CA2511521C (en) 2002-12-30 2012-02-07 Angiotech International Ag Drug delivery from rapid gelling polymer composition
ES2348303T3 (es) 2003-12-08 2010-12-02 Cpex Pharmaceuticals, Inc. Composiciones farmacauticas y procedimientos de tratamiento con insulina.
US20060078580A1 (en) * 2004-10-08 2006-04-13 Mediquest Therapeutics, Inc. Organo-gel formulations for therapeutic applications
US7740875B2 (en) * 2004-10-08 2010-06-22 Mediquest Therapeutics, Inc. Organo-gel formulations for therapeutic applications
SI1867332T1 (sl) 2005-04-07 2011-11-30 Toyama Chemical Co Ltd Farmacevtska sestava in postopek z rabo v kombinaciji s protiglivičnim sredstvom
RU2429843C2 (ru) * 2006-10-06 2011-09-27 Тояма Кемикал Ко., Лтд. Фармацевтическая композиция, включающая производное фениламидина, и способ применения фармацевтической композиции в комбинации с противогрибковым средством
US20080167312A1 (en) * 2006-12-08 2008-07-10 Auspex Pharmaceuticals, Inc. Preparation and utility of substituted allylamines
WO2009089549A1 (en) 2008-01-11 2009-07-16 Massachusetts Eye & Ear Infirmary Conditional-stop dimerizable caspase transgenic animals
EP3008192B1 (en) 2013-06-11 2019-07-17 Takara Bio USA, Inc. Protein enriched microvesicles and methods of making and using the same

Family Cites Families (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4144346A (en) * 1977-01-31 1979-03-13 Janssen Pharmaceutica N.V. Novel 1-(1,3-dioxolan-2-ylmethyl)-1H-imidazoles
US4218458A (en) * 1978-06-23 1980-08-19 Janssen Pharmaceutica, N.V. Heterocyclic derivatives of (4-aryloxy-methyl-1,3-dioxolan-2-yl)methyl-1H-imidazoles and 1H-1,2,4-triazoles
GB2099818A (en) * 1981-06-06 1982-12-15 Pfizer Ltd Triazoles
US4782059A (en) * 1986-09-29 1988-11-01 Merck & Co., Inc. Method of controlling mycotic infections and compositions therefor
JP2581707B2 (ja) * 1987-10-02 1997-02-12 科研製薬株式会社 抗真菌剤組成物
CA2016738A1 (en) * 1989-06-08 1990-12-08 Philippe Guerry Substituted aminoalkylbenzene derivatives
JPH0338522A (ja) * 1989-07-05 1991-02-19 Maruho Kk 抗真菌性組成物
JPH0338521A (ja) * 1989-07-05 1991-02-19 Maruho Kk 抗真菌性組成物
CA2020888A1 (en) * 1989-07-27 1991-01-28 Philippe Guerry Substituted aminoalkoxybenzene derivatives
US5214046A (en) * 1989-07-27 1993-05-25 Hoffmann-La Roche Inc. Substituted aminoalkoxybenzene anti-fungicidal compositions and use
CA2044533A1 (en) * 1990-06-29 1991-12-30 Philippe Guerry Substituted aminoalkylbiphenyl derivatives
US5696164A (en) * 1994-12-22 1997-12-09 Johnson & Johnson Consumer Products, Inc. Antifungal treatment of nails
JP3038521U (ja) 1996-12-05 1997-06-20 啓次 小峰 排泄物一時保持具用の水溶繊維製ステック状吸液材
JP3038522U (ja) 1996-12-05 1997-06-20 秀俊 筬 カード型紙箱ポプリ

Also Published As

Publication number Publication date
CZ354797A3 (cs) 1998-02-18
AU712914B2 (en) 1999-11-18
HU224920B1 (en) 2006-04-28
DE69629367D1 (de) 2003-09-11
GB9509631D0 (en) 1995-07-05
US5985906A (en) 1999-11-16
IL118219A (en) 2001-08-26
CZ291144B6 (cs) 2002-12-11
NO975134D0 (no) 1997-11-07
DK0824350T3 (da) 2003-11-03
PL322749A1 (en) 1998-02-16
DE69629367T2 (de) 2004-06-09
CN1184427A (zh) 1998-06-10
JPH11504931A (ja) 1999-05-11
CY2496B1 (en) 2005-09-02
TW464492B (en) 2001-11-21
FI120079B (fi) 2009-06-30
ZA963754B (en) 1997-11-10
NO975134L (no) 1997-11-07
HK1016064A1 (en) 1999-10-29
HUP9801140A3 (en) 2000-07-28
KR19990014708A (ko) 1999-02-25
FI973812A (fi) 1997-11-11
HUP9801140A2 (hu) 1999-01-28
MX9708699A (es) 1998-02-28
NO317030B1 (no) 2004-07-26
EP0824350A1 (en) 1998-02-25
PT824350E (pt) 2003-12-31
CA2219651A1 (en) 1996-11-14
AU5818396A (en) 1996-11-29
WO1996035423A1 (en) 1996-11-14
IL118219A0 (en) 1996-09-12
FI973812A0 (fi) 1997-09-26
EP0824350B1 (en) 2003-08-06
ES2205042T3 (es) 2004-05-01
CN1100539C (zh) 2003-02-05
ATE246504T1 (de) 2003-08-15
KR100443535B1 (ko) 2004-12-17
CA2219651C (en) 2007-03-27

Similar Documents

Publication Publication Date Title
US5985906A (en) Antifungal composition
Fromtling Overview of medically important antifungal azole derivatives
US5434163A (en) Treatment of Cryptococcus neoformans infection
US4782059A (en) Method of controlling mycotic infections and compositions therefor
US20100004205A1 (en) Pharmaceutical compositions
AU739591B2 (en) Treatment of fungal infections using a combination of an anti-fungal compound and an N-alkyl heterocyclic compound
JP2020529999A (ja) 酸性pHで活性の増強を示す抗真菌剤
Odds Itraconazole—a new oral antifungal agent with a very broad spectrum of activity in superficial and systemic mycoses
US20010039291A1 (en) Compositions and methods of treatment for cancer or viral infections
US4894375A (en) Method of controlling mycotic infections and compositions therefor
US9962372B2 (en) Pharmaceutical composition for the treatment of mycosis
US4871741A (en) Method of controlling mycotic infections and compositions therefor
EP1492548B1 (en) Composition for the topical treatment of vulvovaginitis and mycoses
Ghannoum et al. Terbinafine
EP2680857B1 (en) Oleyl phosphocholine for the treatment of mycosis
PL234554B1 (pl) Mieszanina oksytiaminy i ketokonazolu oraz kompozycja farmaceutyczna
Ghannoum et al. Naftifine
Watanabe Clinical Evaluation of Antifungal Agents Used for Deep-Seated Mycotic Infections
CA2479381A1 (en) A use of treatment for fungal infections with a synergistic formulation of antifungal agent, menthol and menthyl acetate
US20130345177A1 (en) Oleyl Phosphocholine for the Treatment of Mycosis